Production assistance for cellular therapies (PACT)- cell processing facilities cell manufacturing and process development services for RSA PCT0002-02: lovo PACT center study
Ended Awarded Last action
- Contract number
- 75N92019F00005
- Awardee
-
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. UEI DVHKP4N619V9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $525,665
Award facts
- Opportunity
-
- 75N92018R0066 Solicitation number
- Contract value 100% obligated
- $525,665.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Tampa, FL 33612, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | -$42,828 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $568,493 |
About this award
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a National Cancer Institute-designated comprehensive cancer center in Tampa, Florida, was awarded a delivery order valued at $525,665.30 by the National Heart, Lung, and Blood Institute under the Production Assistance for Cellular Therapies–Cell Processing Facilities (PACT-CPF) master IDIQ vehicle. This contract, issued on October 31, 2018, with completion targeted for June 1, 2020, calls for cell manufacturing and process development services supporting two distinct research initiatives: RSA PCT0002-02 (LOVO PACT Center Study) and PCT0003-01 (CD4+ Central Memory T Cell Expansion for use with allogenic hematopoietic cell transplantation). The award carries a cost-no-fee pricing structure and was not designated as a set-aside contract.
The work will be performed at Moffitt's cell processing facilities in Tampa, Florida. As a leading research and treatment institution with extensive expertise in immunotherapy and cellular biology, Moffitt is well-positioned to deliver the specialized cell manufacturing and process development services required under this contract. The PACT-CPF vehicle itself supports critical national efforts to advance cellular therapy manufacturing capabilities, enabling the development and optimization of innovative cell-based treatments for various medical conditions under the auspices of the National Heart, Lung, and Blood Institute.
Quick answers
Who was awarded contract 75N92019F00005?
75N92019F00005 was awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on October 31, 2018.
How much is contract 75N92019F00005 worth?
The government has obligated $525,665 on 75N92019F00005.
Is contract 75N92019F00005 an order under another contract?
Yes. 75N92019F00005 is a delivery order under HHSN268201600013I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract 75N92019F00005 competed?
The extent of competition for 75N92019F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award